Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/2041Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Thomas, Zakir | - |
| dc.date.accessioned | 2008-09-18T10:17:30Z | - |
| dc.date.available | 2008-09-18T10:17:30Z | - |
| dc.date.issued | 2008-09 | - |
| dc.identifier.issn | 0971-5544 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/2041 | - |
| dc.description | 523-535 | en_US |
| dc.description.abstract | Branding of a drug raises important trademark principles. Some of the important trademark law decisions have come up in the area of pharmaceutical branding. This article examines these decisions, practises in the market and analyses legal issues surrounding trademark in pharmaceutical field. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.source | JIPR Vol.13(5) [September 2008] | en_US |
| dc.subject | Pharmaceutical branding | en_US |
| dc.subject | Generic name | en_US |
| dc.subject | Infringement | en_US |
| dc.subject | Passing off | en_US |
| dc.subject | Trademark law | en_US |
| dc.title | Legal Issues in Branding Medicinal Products | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | JIPR Vol.13(5) [September 2008] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| JIPR 13(5) 523-535.pdf | 88.81 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.